Lung cancer can remain dormant in the body for many years before emerging in an aggressive form, according to new research.
Two recently published genetic studies have the potential to advance treatments for small cell lung cancer (SCLC), a cancer type in which treatment advances are rare.
A history of prior cancer can exclude many individuals from participation in clinical trails related to lung cancer, even when the prior cancer is unlikely to interfere with treatment outcomes.
Increased tobacco exposure is linked with a higher risk of developing second primary lung cancers (SPLCs).
Researchers have found that there is a strong association between lung tissue with human papillomavirus (HPV) infection.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|